Literature DB >> 25030951

Evaluation of intrafraction motion of the organs at risk in image-based brachytherapy of cervical cancer.

Vijai Simha1, Firuza Darius Patel2, Suresh Chander Sharma2, Bhavana Rai2, Arun Singh Oinam2, Rahul krishnatry3, Bhaswanth Dhanireddy2.   

Abstract

PURPOSE/
INTRODUCTION: To assess the variation in the doses received by the organs at risk (OARs) that can occur during treatment planning of cervical cancer by image-based brachytherapy. METHODS AND MATERIALS: After intracavitary application, two sets of images-CT and MRI-were obtained. The two sets of images were fused together with respect to the applicator. Contouring was done separately on CT and MR images. Dose received by the OARs on CT images with respect to the plans made on the MR images was estimated and compared with those on the MR images.
RESULTS: Although there was always a difference between the dose received by the OARs based on the CT and MRI contours, it was not significant for the bladder and rectum; 2 cc doses differed by 0.49 Gy (±0.44) p = 0.28 for the bladder and 0.30 Gy (±0.29) p = 0.16 for the rectum. The 1 cc and 0.1 cc differences were also not significant. However for the sigmoid colon, there was significant intrafraction variation in the 2 cc doses 0.61 (±0.6) p = 0.001, 1 cc doses 0.73 (±0.67) Gy p = 0.00, and 0.1 cc dose 0.97 (±0.93) Gy p = 0.009.
CONCLUSIONS: The variation in the doses to the OARs must be considered while weighing target coverage against overdose to the OARs. Although not significant for the bladder and rectum, it was significant for the sigmoid colon. Estimated doses to OARs on the planning system may not be the same dose delivered at the time of treatment.
Copyright © 2014 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Image-based brachytherapy; Intrafraction changes; Intrafraction motion; Optimization; Organ motion; Organs at risk

Mesh:

Year:  2014        PMID: 25030951     DOI: 10.1016/j.brachy.2014.05.016

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  6 in total

1.  Comparison of predictive performance for toxicity by accumulative dose of DVH parameter addition and DIR addition for cervical cancer patients.

Authors:  Yuya Miyasaka; Noriyuki Kadoya; Rei Umezawa; Yoshiki Takayama; Kengo Ito; Takaya Yamamoto; Shohei Tanaka; Suguru Dobashi; Ken Takeda; Kenji Nemoto; Takeo Iwai; Keiichi Jingu
Journal:  J Radiat Res       Date:  2021-01-01       Impact factor: 2.724

2.  Excess dose-related parameters (Vex, Rex, and iRex): novel predictors and late toxicity correlations in cervical cancer image-guided adaptive brachytherapy.

Authors:  Tissana Prasartseree; Pittaya Dankulchai; Peter J Hoskin
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

3.  Dynamic Changes in Bladder Morphology Over Time in Cervical Cancer Patients.

Authors:  Fu Jin; Qiang Liu; Huanli Luo; Rui Zhu; Yanhong Mou; Yongzhong Wu; Ying Wang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

4.  Artificial neural network based gynaecological image-guided adaptive brachytherapy treatment planning correction of intra-fractional organs at risk dose variation.

Authors:  Ramin Jaberi; Zahra Siavashpour; Mahmoud Reza Aghamiri; Christian Kirisits; Reza Ghaderi
Journal:  J Contemp Brachytherapy       Date:  2017-12-30

5.  First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy.

Authors:  Andre Karius; Vratislav Strnad; Michael Lotter; Stephan Kreppner; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2022-03-12       Impact factor: 4.033

6.  Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.

Authors:  Junfang Yan; Jiawei Zhu; Kai Chen; Lang Yu; Fuquan Zhang
Journal:  Radiat Oncol       Date:  2021-08-04       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.